Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel mGlu5 receptor PAM developed by Janssen for the treatment of schizophrenia

Sep. 18, 2012

TB Alliance presents data for their next-generation tuberculosis drug candidate

Sep. 18, 2012

Novel topical antiviral plant extract for HSV

Sep. 18, 2012

Promising in vitro and in vivo results reported for novel dual c-Met/Ron inhibitor

Sep. 18, 2012

Citrulline could serve as a new biomarker of Leigh's disease

Sep. 18, 2012

Novo-23 presented as novel antitubercular drug candidate with a new antibiotic target

Sep. 17, 2012

GeoVax presents promising phase II results for their HIV vaccines

Sep. 17, 2012

Amgen presents novel series of beta-secretase inhibitors

Sep. 17, 2012

PSAP evaluated as a new urinary biomarker for monitoring Fabry's disease

Sep. 14, 2012

First-in-human results presented for a novel anti-HIV-1 vaccine

Sep. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...